Pitt Shield

Disruption of the Blood-Spinal Cord Barrier using Low-Intensity Focused Ultrasound in a Rat Model.

Authors: Bhimreddy M, Routkevitch D, Hersh AM, Mohammadabadi A, Menta AK, Jiang K, Weber-Levine C, Davidar AD, Punnoose J, Kempski Leadingham KM, Doloff JC, Tyler B, Theodore N, Manbachi A

Low-intensity focused ultrasound (LIFU) uses ultrasonic pulsations at lower intensities than ultrasound and is being tested as a reversible and precise neuromodulatory technology. Although LIFU-mediated blood-brain barrier (BBB) opening has been explored in detail, no standardized technique for blood-spinal cord barrier (BSCB) opening has been established to date. Therefore, this protocol presents a method for successful BSCB disruption using LIFU sonication in a rat model, including descriptions of animal preparation, microbubble administration, target selection and localization, as well as BSCB disruption visualization and confirmation. The approach reported here is particularly useful for researchers who need a fast and cost-effective method to test and confirm target localization and precise BSCB disruption in a small animal model with a focused ultrasound transducer, evaluate the BSCB efficacy of sonication parameters, or explore applications for LIFU at the spinal cord, such as drug delivery, immunomodulation, and neuromodulation. Optimizing this protocol for individual use is recommended, especially for advancing future preclinical, clinical, and translational work.

Introduction

Purpose Drug delivery with BBB opening
Study Objective To present a protocol for reliably disrupting the blood-spinal cord barrier (BSCB) with low-intensity focused ultrasound (LIFU) in a rat model.
Animal model / Human subject Rat (strain not specified, age not specified, sex not specified)
Disease model Healthy

Outcomes and Safety

Summary of Outcomes Low-intensity focused ultrasound (with microbubble administration) produced reliable, localized disruption/opening of the blood–spinal cord barrier (BSCB) in rats, with target localization and BSCB disruption confirmed; specific sonication parameter values were not provided in the excerpt.
Safety-related matter The provided text does not report any safety concerns or adverse effects related to LIFU-mediated BSCB disruption; no adverse events or safety data are mentioned.

Brain Region

Visualization unavailable

Ultrasound Parameters

FUS Mode pulsed
Focal Characteristics Focal depth: None; Focal length: None; Aperture size: None

We are open to feedback. If you see a mistake or have a suggestion, please contact us.

← Back to Search